This work demonstrates red-bodipy emitters achieving high quantum yield and narrow emission in OLEDs, suggesting efficiency improvements for color standards.
Boron dipyrromethene (BODIPY) fluorescent molecules are known for their high photoluminescence quantum yield (PLQY) and narrow emission. However, achieving proper deep-red narrow emission that meets BT2020 standards, along with a high PLQY, remains a critical task till date. Herein, we demonstrate the development of four red fluorescent emitters, namely, DBF-BODIPY, DFP-BODIPY, TFP-BODIPY, and PFP-BODIPY, by substituting dibenzofuranyl and fluorophenyl units at the meso-position of BODIPY respectively. As the electron-withdrawing nature of the substituents varies, it significantly alters the emission toward 619 to 635 nm with a narrow full width at half-maximum (fwhm) of 39 to 33 nm, respectively. Specifically, pentafluorophenyl substitution narrows the fwhm at the deep-red region in toluene solution with CIE coordinates of (0.70, 0.30), nearly satisfying the BT2020 standards. Among these emitters, DBF-BODIPY showed the highest PLQY of 98%. Further, thermally activated delayed fluorescence (TADF)-sensitized organic light-emitting diodes (OLEDs) based on these emitters were studied. Among the fabricated OLEDs, the DBF-BODIPY-based OLED showed an EQEmax of 17.0% with an emission maximum at 619 nm. The corresponding device exhibited a high operational lifetime (LT90) of 152 h at an initial luminescence of 5000 cd/m2.
No takes yet. Share an insight, caveat, or question.
Chandra et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: